Silver Spring’s Aziyo Biologics inks distribution deal with LeMaitre Vascular following layoffs

Silver Spring’s Aziyo Biologics Inc. (NASDAQ: AZYO) has inked an agreement that gives Burlington, Massachusetts-based LeMaitre Vascular Inc. (NASDAQ: LMAT) exclusive U.S. distribution rights to the local firm’s cardiovascular business line, which includes products for cardiac tissue and vascular repair surgeries. The three-year deal can be extended if both companies agree, and either can end it due to bankruptcy, breach of the contract or other events — including if LeMaitre doesn’t meet minimum volume purchase requirements, Aziyo said in a Securities and Exchange Commission filing.